Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Immunology | Family Medicine
Atopic Dermatitis Clinical Trials
A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Mobile :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Arizona
Hot Springs :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
California
La Jolla : Research Center
Systemic Sclerosis / Scleroderma Study
Los Angeles : Research Center
Systemic Sclerosis / Scleroderma Study
Redwood City : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Encino :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Oceanside :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
San Diego :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Colorado
Denver :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Connecticut
Farmington : Research Center
Systemic Sclerosis / Scleroderma Study
District of Columbia
Washington : Research Center
Systemic Sclerosis / Scleroderma Study
Florida
Tampa : Olympian Clinical Research
Do you have Atopic Dermatitis and have been treated with Protopic (tacrolimus ointment)?
View More »
Jacksonville :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Miami :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Miramar :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Orange Park :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Pinellas Park :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Tampa :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Tampa :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Idaho
Boise :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Illinois
Chicago : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Chicago : Northwestern University, Department of Dermatology
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
Indiana
Carmel :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Maryland
Baltimore : Research Center
Systemic Sclerosis / Scleroderma Study
Massachusetts
Boston : Research Center
Systemic Sclerosis / Scleroderma Study
Michigan
Ann Arbor : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Fort Gratiot :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
New Jersey
New Brunswick : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Verona :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
New York
Lake Success : Research Center
Systemic Sclerosis / Scleroderma Study
New York : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
New York : Call for Information (Investigational Site 0002) Updated
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
Stony Brook :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
North Carolina
High Point :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Salem :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Winston-Salem : Wake Forest University Health Sciences
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Ohio
Cleveland : Research Center
Systemic Sclerosis / Scleroderma Study
Toledo : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Sylvania :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Oklahoma
Oklahoma City : Research Center
Systemic Sclerosis / Scleroderma Study
Oregon
Lake Oswego :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Portland :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Portland :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Portland : Oregon Health & Science University Center for Health & Healing
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
Portland : Oregon Health & Science University, Department of Dermatology
Eczema Prevention Study
View More »
Portland : Oregon Health & Science University Department of Dermatology
VANOS Cream and Skin Barrier Function
Pennsylvania
Philadelphia : Paddington Testing Co., Inc
Atopic Dermatitis
Philadelphia : Research Center
Systemic Sclerosis / Scleroderma Study
Pittsburgh : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Philadelphia : Registry
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
Rhode Island
Johnston :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
South Carolina
Charleston : Research Center
Systemic Sclerosis / Scleroderma Study
Texas
Houston : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
College Station :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
College Station :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Dallas :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Houston : University of Texas Medical School - Houston
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
San Antonio :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
San Antonio :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Webster :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Utah
Salt Lake City : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Draper :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Virginia
Henrico :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Norfolk :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Washington
Seattle : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Spokane :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Austria
Vienna : Novartis Investigative Site
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
Canada
London, Ontario : Research Center
Systemic Sclerosis / Scleroderma Study
Montreal, Quebec : Research Center
Systemic Sclerosis / Scleroderma Study
Toronto, Ontario : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Kirkland : Merck Frosst Canada Ltd. Updated
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
Czech Republic
Nachod :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Svitavy :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Usti nad Labem :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Estonia
Tallinn :
Emollients in the Management of Atopic Dermatitis
Tartu :
Emollients in the Management of Atopic Dermatitis
Finland
Helsinki :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Tampere :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
France
Bordeaux : Research Center
Systemic Sclerosis / Scleroderma Study
Caen : Research Center
Systemic Sclerosis / Scleroderma Study
Lille : Research Center
Systemic Sclerosis / Scleroderma Study
Paris : Research Center
Systemic Sclerosis / Scleroderma Study
Strasbourg : Research Center
Systemic Sclerosis / Scleroderma Study
Toulouse : Research Center
Systemic Sclerosis / Scleroderma Study
Germany
Bad Nauheim : Research Center
Systemic Sclerosis / Scleroderma Study
Baden-Baden : Research Center
Systemic Sclerosis / Scleroderma Study
Berlin : Research Center
Systemic Sclerosis / Scleroderma Study
Bochum : Research Center
Systemic Sclerosis / Scleroderma Study
Dresden : Research Center
Systemic Sclerosis / Scleroderma Study
Erlangen : Research Center
Systemic Sclerosis / Scleroderma Study
Frankfurt/Main : Research Center
Systemic Sclerosis / Scleroderma Study
Hamburg : Research Center
Systemic Sclerosis / Scleroderma Study
Köln : Research Center
Systemic Sclerosis / Scleroderma Study
Tübingen : Research Center
Systemic Sclerosis / Scleroderma Study
Ulm : Research Center
Systemic Sclerosis / Scleroderma Study
View More »
Berlin :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Berlin :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Bonn :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Dresden :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Erfurt :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Frankfurt :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Frankfurt :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Gera :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Hannover :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Heidelberg :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Kiel :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Mahlow :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Mainz :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Münster :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Osnabrueck :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Tuebingen :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Hungary
Kaposvar :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szeged :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szekszard :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szolnok :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lithuania
Vilnius :
Emollients in the Management of Atopic Dermatitis
Poland
Bydgoszcz :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Gdansk :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lodz :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lublin :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Poznan :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
View More »
Warszawa :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Warszawa :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Witosa :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Wroclaw :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Taiwan
United Kingdom
Cannock : Research Center
Systemic Sclerosis / Scleroderma Study
Dundee : Research Center
Systemic Sclerosis / Scleroderma Study
Edinburgh : Research Center
Systemic Sclerosis / Scleroderma Study
Leeds : Research Center
Systemic Sclerosis / Scleroderma Study
Liverpool : Research Center
Systemic Sclerosis / Scleroderma Study
London : Research Center
Systemic Sclerosis / Scleroderma Study
Middlesbrough : Research Center
Systemic Sclerosis / Scleroderma Study
Newcastle upon Tyne : Research Center
Systemic Sclerosis / Scleroderma Study
Romford : Research Center
Systemic Sclerosis / Scleroderma Study